HPS Pharmacies wish to give notice that all suppliers are experiencing a supply interruption for cefalexin powder for oral liquid as follows:

Product ARTG Estimated Return Date
Cefalexin Sandoz 125mg/5mL 78981 End January 2023
Cefalexin Sandoz 250mg/5mL 78982 Mid-January 2023
Ibilex® 125mg/5mL 92972 End January 2023
Ibilex® 250mg/5mL 92973 End February 2023
Keflex® 125mg/5mL 92970 End December 2022
Keflex® 250mg/5mL 92971 End December 2022

The Therapeutic Goods Administration (TGA) has made a Serious Scarcity Substitution Instrument (SSSI) to help manage this out of stock situation. The SSSI allows pharmacists to substitute an alternative cefalexin syrup or suspension when the prescribed one is unavailable. Alternatively, cefalexin 250mg capsules may be given if the patient can swallow a capsule and the dose is divisible by 250.

This SSSI is in force until 31 July 2023, unless revoked earlier by the TGA.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates